Skip to main content
. 2023 Dec 6;24(24):17201. doi: 10.3390/ijms242417201

Figure 1.

Figure 1

Pharmacokinetics of EPA and DHA in IMD-Omega and Omacor®. (A) Concentration (mg/dL) of plasma EPA in IMD-Omega and Omacor® over 72 h. (B) Concentration (mg/dL) of plasma DHA in IMD-Omega and Omacor® over 72 h. (C) AUC0–72 for the plasma EPA in IMD-Omega and Omacor® over 72 h. (D) AUC0–72 or the plasma DHA in IMD-Omega and Omacor® over 72 h. All results are expressed as mean ± SD (n = 12). *** p value < 0.001; ** p value < 0.005 (t-test).